Planning Head and Neck radiotherapy in contrast CT: viability for AAA and AcurosXB




Radiotherapy, Computed tomography, Contrast Agent, Dose Calculation, AAA, AcurosXB, VMAT, IMRT


Background and purpose: many radiotherapy services execute two computed tomography (CT) scans for the treatment of head and neck (H&N) tumors: with (contrast CT) or without contrast (non-contrast CT), for dose calculation and target volume delineation, respectively. However, performing two CT scans brings problems such as unnecessary exposure of the patient to radiation and errors in CT images fusion. Therefore, the objective of this study was to verify the possibility of performing only the contrast CT as the routine for dose calculation with AAA and AcurosXB. Materials and methods: contrast and non-contrast CT scans from 77 patients were retrospectively analyzed and the Hounsfield Unit (HU) values ​​of the target volume and some organs at risk (as well as dosimetric values ​​were evaluated and compared. Statistical analysis was performed by calculating the intraclass correlation coefficient (ICC), assuming a significance level of 5%. Results: there is a correlation between the values ​​obtained for both HU and dosimetric data between the CT scans since the ICC was close to 1 and the p-value was lower than 0.05 for all cases. Conclusion: it is possible to perform only the contrast CT in the simulation routine for the treatment of patients with head and neck tumors.

Keywords: Radiotherapy; Computed tomography; Contrast Agent; Dose Calculation; AAA; AcurosXB; VMAT; IMRT


Não há dados estatísticos.


WHO WHO-. World Heath Statistics. 2021. 136 p.

WHO. What is cancer. 2018.

INCA. INCIDÊNCIA DE CÂNCER NO BRASIl. Vol. 1, Journal of Materials Processing Technology. 2020. 1–8 p.

C W, S W, SJ S, N W, J K, H R, et al. HPV - A different view on Head and Neck Cancer. Laryngorhinootologie. 2018 Mar;97(S 01):S48–113.

Galbiatti ALS, Padovani-Junior JA, Maníglia JV, Rodrigues CDS, Pavarino ÉC, Goloni-Bertollo EM. Câncer de cabeça e pescoço: causas, prevenção e tratamento. Braz J Otorhinolaryngol. 2013;79(2):239–47.

Jethwa AR, Khariwala SS. Tobacco-related carcinogenesis in head and neck cancer. Cancer Metastasis Rev 2017 363. 2017 Aug;36(3):411–23.

D H, E G, M P, M H, P B. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol Off J Eur Soc Med Oncol. 2019 May;30(5):744–56.

Minicucci EM, Da Silva GN, Salvadori DMF. Relationship between head and neck cancer therapy and some genetic endpoints. World J Clin Oncol. 2014;5(2):93–102.

Abreu CECV, Ferreira PPR, Moraes FY de, Neves Jr WFP, Gadia R, Carvalho H de A. Stereotactic body radiotherapy in lung cancer: an update. J Bras Pneumol. 2015;41(4):376–87.

Ramm U, Damrau M, Mose S, Manegold KH, Rahl CG, Böttcher HD. Influence of CT contrast agents on dose calculations in a 3D treatment planning system. Phys Med Biol. 2001 Oct;46(10):2631–5.

Liauw S, Amdur R, Mendenhall W, Palta J, Kim S. The Effect of Intravenous Contrast on Intensity-Modulated Radiation Therapy Dose Calculations for Head and Neck Cancer. Am J Clin Oncol. 2005 Nov;28:456–9.

Choi Y, Kim JK, Lee HS, Hur WJ, Hong YS, Park S, et al. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer. Radiother Oncol. 2006;81(2):158–62.

Yan C, Combine AG, Bednarz G, Lalonde RJ, Hu B, Dickens K, et al. Clinical implementation and evaluation of the Acuros dose calculation algorithm. J Appl Clin Med Phys. 2017;18(5):195–209.

Sievinen J, Ulmer W, Kaissl W. AAA photon dose calculation model in Eclipse. Palo Alto Varian Med Syst. 2005;Varian doc:1–23.

Gregory A. Failla, Todd Wareing, Yves Archambault ST. Acuros XB advanced dose calculation for the Eclipse treatment planning system.

Seniwal B, Bhatt CP, Fonseca T. Comparison of dosimetric accuracy of acuros XB and analytical anisotropic algorithm against Monte Carlo technique. Biomed Phys Eng Express. 2020 Jan;6.

Fenchel S, Fleiter TR, Aschoff AJ, van Gessel R, Brambs HJ, Merkle EM. Effect of iodine concentration of contrast media on contrast enhancement in multislice CT of the pancreas. Br J Radiol. 2004;77(922):821–30.

Engeroff B, Kopka L, Harz C, Grabbe E. [Impact of different iodine concentrations on abdominal enhancement in biphasic multislice helical CT (MS-CT)]. Rofo. 2001 Oct;173(10):938–41.

Zhu F, Wu W, Zhu F, Wang Y, Wang Y, Xia T. Influence of computed tomography contrast agent on radiotherapy dose calculation for pancreatic carcinoma: A dosimetric study based on tomotherapy and volumetric-modulated arc therapy techniques. Med Dosim Off J Am Assoc Med Dosim. 2017;42(4):317–25.

Tian JM, Shen YH, Yang XW, Liang SA, Shan L, Li HL, et al. Antifungal cyclic peptides from Psammosilene tunicoides. J Nat Prod. 2010;73(12):1987–92.

Li H-S, Chen J-H, Zhang W, Shang D-P, Li B-S, Sun T, et al. Influence of intravenous contrast medium on dose calculation using CT in treatment planning for oesophageal cancer. Asian Pac J Cancer Prev. 2013;14(3):1609–14.

Shi W, Liu C, Lu B, Yeung A, Newlin HE, Amdur RJ, et al. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. Am J Clin Oncol. 2010 Apr;33(2):153–6.

Shibamoto Y, Naruse A, Fukuma H, Ayakawa S, Sugie C, Tomita N. Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions: a prospective study. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2007 Jul;84(1):52–5.




Como Citar

Nardi, P. N., Beraldo Oliveira, B., de Faria Morato, L., Carmello Guimarães, L. F., Altei, W. F., & Giglioli, M. (2022). Planning Head and Neck radiotherapy in contrast CT: viability for AAA and AcurosXB. Revista Brasileira De Física Médica, 16, 652.



Artigo Original

Artigos mais lidos pelo mesmo(s) autor(es)